Skip to main content

Harvest Health & Recreation Inc (HARV-CN) Quote

Unchecking box will stop auto data updates
CSE Real-Time Last Sale CAD
Today's Change
Price Quote as of

Today's Trading

Day Low 3.000
Day High 3.620
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

More stories below advertisement

Harvest Health & Recreation Inc is a vertically integrated cannabis company. The company's segment include the production and sale of cannabis with three business areas namely Cultivation, Processing, and Retail dispensaries. It has expanded throughout Arizona, Maryland, and Pennsylvania.


Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio


Corporate earnings are provided from Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Latest Press Releases

Patients Forego Traditional Prescriptions in Favor of Cannabis
- PR Newswire - Tue Oct 8, 8:00AM CDT
PR Newswire - CMTX
Tue Oct 8, 8:00AM CDT
Prescription drugs range from depressants and opioids to stimulants and are generally known to be highly addictive and capable of causing severe harm to the heart, brain, and liver with repeated use. Consequently, if patients abuse prescription drugs, it can ultimately prove to be life-threatening. Now, the concern over the growing epidemic of prescription drug abuse has led medical institutions and professionals to reconsider what patients are prescribed. Notably, in regions where cannabis is legalized for medical purposes, more and more patients are beginning to use cannabis as an alternative to pharmaceutical medications. Specifically, Canada has witnessed its medical patient user base grow significantly over the past several years. There were 296,702 patients registered under Health Canada's Access to Cannabis for Medical Purposes Regulations (ACMPR) program as of March 2018. Compared to the same period a year prior, the number of registered patients grew by 76.9%. The robust growth reflects how rapidly the user base is growing as more people turn to cannabis as a medical alternative. Moreover, the global user base is projected to continually grow as well as more countries begin to implement medical cannabis programs. And according to data compiled by MarketsandMarkets, the global cannabis market is projected to grow from USD 10.3 Billion in 2018 to USD 39.4 Billion by 2023. Furthermore, the market is anticipated to grow at a CAGR of 30.7% during the forecast period. Newleaf Brands Inc. (OTC: NLBIF) (CSE: NLB), The Supreme Cannabis Company, Inc. (OTC: SPRWF) (TSX: FIRE), Auxly Cannabis Group Inc. (OTC: CBWTF) (TSX-V: XLY), Planet 13 Holdings Inc. (OTC: PLNHF) (CSE: PLTH), Harvest Health & Recreation Inc. (OTC: HRVSF) (CSE: HARV),
Cannabis Use Continues to Spread Despite Legal Holdups
- PR Newswire - Thu Oct 3, 8:00AM CDT
PR Newswire - CMTX
Thu Oct 3, 8:00AM CDT
Illinois became the 11th U.S. state to legalize the adult-use of cannabis after Governor J.B. Pritzker signed a recreational marijuana legalization bill in late June. The legislation is expected to take effect on January 1st, 2020. Illinois has already had its medical cannabis program operational since 2013 and as of June 2019, had over 73,000 qualifying patients in medical cannabis programs. Now, with the passage of the legislation, market analysts predict that the recreational segment will eclipse the medical segment, as the Marijuana Business Daily projects that Illinois' recreational market could generate upwards of USD 2.5 Billion annually, depending on the large role tourists play. Overall, the law will allow consumers 21 years and older to purchase up to 30 grams of cannabis flower or five grams of concentrates. Moreover, Illinois' residents will be allowed to cultivate up to five plants within their households. Overall, the state's legalization marks yet another major milestone within the cannabis industry. However, the federal legality of cannabis is still a conflict of interest swirling around the country's politicians, even as nearly seven-in-ten Democrats support the legalization of marijuana, as do 75% of the independents who lean towards the Democratic party, according to Pew Research Center. On the other hand, the Republicans are divided, with only 45% in favor of and 51% opposed to legalization. And while the Republican public still leans toward the opposition, the number of those supporting legalization has drastically increased from 39% in 2015. Despite the federal split on the broad cannabis industry, the CBD marketplace is gaining traction within the U.S. Smart Decision, Inc. (OTC: SDEC), Harvest Health & Recreation Inc. (OTC: HRVSF) (CSE: HARV), MariMed, Inc. (OTC: MRMD), Aleafia Health Inc. (OTC: ALEAF) (TSX: ALEF), Emerald Health Therapeutics Inc. (OTC: EMHTF) (TSX-V: EMH)
CBD Products Continue to Reap the Benefits of Legalization
- PR Newswire Europe - Fri Sep 6, 8:59AM CDT
PR Newswire Europe - CMTX
Fri Sep 6, 8:59AM CDT News Commentary
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 2.700 +25.56% increase
on 10/10/19
Period Open:6.720
Price movement based on the high, low and last over the given period.
6.720 -49.55% decrease
on 09/12/19
-3.330 (-49.55%) decrease
since 09/11/19
3-Month 2.700 +25.56% increase
on 10/10/19
Period Open:7.990
Price movement based on the high, low and last over the given period.
8.200 -58.66% decrease
on 07/12/19
-4.600 (-57.57%) decrease
since 07/11/19
52-Week 2.700 +25.56% increase
on 10/10/19
Period Open:6.980
Price movement based on the high, low and last over the given period.
14.500 -76.62% decrease
on 04/04/19
-3.590 (-51.43%) decrease
since 11/15/18

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2019.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).